Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia

Background: Chinese medicine (CM) is widely used for treating hyperlipidemias, especially in China. However, the heterogeneity of outcomes measured and reported across trials exacerbates the obstacles of evidence synthesis and effectiveness comparison. In this study, we develop a core outcome set (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Geng, Han, Ruxue, Lin, Mingjun, Wen, Zehuai, Chen, Xiankun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108338/
https://www.ncbi.nlm.nih.gov/pubmed/35586053
http://dx.doi.org/10.3389/fphar.2022.847101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108338/
https://www.ncbi.nlm.nih.gov/pubmed/35586053
http://dx.doi.org/10.3389/fphar.2022.847101

Ejemplares similares